Cite

HARVARD Citation

    Kamperidis, N. et al. (2021). Clinical, biomarker and endoscopic outcomes in patients with Crohn's disease treated with Ustekinumab: Multi‐centre real world study. GastroHep. 3 (3), pp. 151-160. [Online]. 
  
Back to record